CHST11 and posterior cortical atrophy: From the top 120 candidates tested in qMSP, 72 were validated (PCa n = 50; controls n = 35), leading to a panel of 14/72 DMGs (including AKR1B1HES5, CHST11, GAS6, GRASP, ITPRIPL1, KCNB2, MAX.chr3.6187, AX.chr3.8028, SCOL3A1, SERPINB9, ST6GALNAC2, WNT3A, and ZNF655) after multiplexing and filtering for its use in liquid biopsy.